MAPK3 and breast cancer: The results shown in Figure 3 and 4 indicated the involvement of ERK1/2 and its downstream targets (i.e. c-Jun, cyclin D1 and c-Myc) in CSF-1-induced cell proliferation in breast cancer cells.